Münch group describes coronavirus infection & potential therapies.
SARS-CoV-2 infection profile and therapeutic strategies.
Complementing conventional antibiotics: Frankfurt scientists reveal atomic details for one of Legionella’s enzymatic weapons and develop first inhibitor.
Researchers from IBC2 and BMLS have now made a major step to a better understanding of the genes causing ALS
03 Sep 2021
Congratulations to @IBC2_GU group leader Christian Münch @MuenchLab for receiving the Otto Meyerhof Award 2021 awar… https://t.co/sf8MnVEwFh
01 Sep 2021
Sorry to hear that Ed Fischer passed away - he will never be forgotten @IBC2_GU where he left his signature not onl… https://t.co/NJdHfc6pAJ
06 Jul 2021
Famotidine inhibits inflammatory signalling triggered by #SARSCoV2. Potential insights for #COVID19 therapy by… https://t.co/RPybgHQlW2
05 Jul 2021
Congratulations to @kuncha_santosh for receiveing one of the prestigious @EMBO postdoctoral fellowships 👏 His proje… https://t.co/qG8NMMze6q
FOLLOW ON TWITTER